Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists investigate why breast cancer beats treatments

NCT ID NCT06274515

Recruiting now Knowledge-focused Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This study aims to understand why some breast cancers become resistant to therapy. Researchers will analyze tumor and blood samples from 320 people with HER2-positive, hormone receptor-positive, or triple-negative breast cancer. The goal is to identify changes in cancer cells that allow them to survive treatment, which could lead to better therapies in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm HER2 positive breast carcinoma hormone receptor-positive breast cancer triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

  • AZ Delta (Campus Rumbeke)

    RECRUITING

    Roeselare, 8800, Belgium

  • AZ KLINA

    RECRUITING

    Brasschaat, 2930, Belgium

  • Aalborg Universitetshospital

    RECRUITING

    Aalborg, 9000, Denmark

  • Azienda Ospedaliero - Universitaria di Modena Policlinico

    RECRUITING

    Modena, Emilia-Romagna, 41110, Italy

  • Basingstoke and North Hampshire Hospital

    RECRUITING

    Basingstoke, RG24 9NA, United Kingdom

  • CHU de Liège (Sart Tilman)

    RECRUITING

    Liège, 4000, Belgium

  • Christie Hospital NHS Trust

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Rome, Lazio, 00168, Italy

  • HM Sanchinarro ? CIOCC

    RECRUITING

    Madrid, 28050, Spain

  • Helsinki University Central Hospital

    RECRUITING

    Helsinki, 00029, Finland

  • Hospital Clínico Universitario de Valencia

    RECRUITING

    Valencia, 46010, Spain

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario Virgen del Rocio

    RECRUITING

    Seville, 41013, Spain

  • I.R.S.T Srl IRCCS

    RECRUITING

    Meldola, Emilia-Romagna, 47014, Italy

  • Imperial College Healthcare NHS Trust

    RECRUITING

    London, W6 8RF, United Kingdom

  • Institut Jules Bordet

    RECRUITING

    Anderlecht, 1070, Belgium

  • Irccs Istituto Europeo Di Oncologia (IEO)

    RECRUITING

    Milan, Lombardy, 20141, Italy

  • Irccs Istituto Nazionale Dei Tumori (Int)

    RECRUITING

    Milan, Lombardy, 20133, Italy

  • KEM/Evang. Kliniken Essen Mitte gGmbH

    RECRUITING

    Essen, 45136, Germany

  • Oslo university hospital Radiumhospitalet

    WITHDRAWN

    Oslo, 0424, Norway

  • Ospedale San Raffaele S.r.l. - PPDS

    RECRUITING

    Milan, Lombardy, 20132, Italy

  • RCCS - Centro di Riferimento

    RECRUITING

    Aviano (PN), Friuli Venezia Giulia, 33081, Italy

  • Sjællands Universitetshospital, Næstved

    RECRUITING

    Næstved, 4700, Denmark

  • St. Elisabeth Krankenhaus Köln GmbH

    RECRUITING

    Cologne, 50935, Germany

  • Tampere University Hospital

    RECRUITING

    Tampere, 33520, Finland

  • Universitätsfrauenklinik Ulm

    RECRUITING

    Ulm, 89075, Germany

  • Universitätsklinikum Mannheim

    RECRUITING

    Mannheim, 68167, Germany

  • ViDia Christliche Kliniken Karlsruhe, Vincentius-Diakonissen-Kliniken gAG

    RECRUITING

    Karlsruhe, 76135, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.